Company profile for Cerecin

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cerecin is a healthcare company with almost 20 years of innovation and leadership in brain health. We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases. Cerecin is a global company headquartered in Singapore and the USA and our ther...
Cerecin is a healthcare company with almost 20 years of innovation and leadership in brain health. We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases. Cerecin is a global company headquartered in Singapore and the USA and our therapies are developed for persons around the world.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
Cerecin Pte. Ltd. 8 Shenton Way #08-02 AXA Tower
Telephone
Telephone
+65 6813 2999
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/cerecin-joins-nihr-healthtech-research-centre-in-brain-health-as-an-industry-partner-302539112.html

PR NEWSWIRE
26 Aug 2025

https://www.prnewswire.com/news-releases/cerecin-strengthens-position-in-neurometabolism-with-addition-to-pipeline-301931761.html

PR NEWSWIRE
19 Sep 2023

https://www.prnewswire.com/news-releases/cerecin-to-present-new-infantile-spasms-data-at-the-35th-international-epilepsy-congress-dublin-2023-301912765.html

PR NEWSWIRE
29 Aug 2023
Cerecin appoints Marc Cantillon as CMO
Cerecin appoints Marc Cantillon as CMO

10 Oct 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/10/10/2530873/0/en/Cerecin-appoints-Dr-Marc-Cantillon-as-Chief-Medical-Officer.html#:~:text=SINGAPORE%20and%20DENVER%2C%20Oct.%2010,(CMO)%20of%20the%20Company.

GLOBENEWSWIRE
10 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty